Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dih ydro-2H-indol-2-one-hydrochloride
US5312925A · kind A · utility
68Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 1992 |
| Grant date | May 17, 1994 |
| Priority date | — |
| Expiry date | Sep 1, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydr o-2H-indole-2-one hydrochloride has advantageous stability for formulation as a neuroleptic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.